Mrs. Sor A Torres-maysonet, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 350 Carr 2, Bo. Espinosa, Vega Alta, PR 00692 Phone: 787-883-1885 Fax: 787-883-1885 |
Mrs. Sylvia Hernandez, RPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Calle Marginal H46, Sta Rita, Vega Alta, PR 00692 Phone: 787-883-1885 Fax: 787-883-1885 |
Centro Ashtar De Terapia Fisica Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Calle Marginal, H 46 Sta Rita, Vega Alta, PR 00692 Phone: 787-883-1885 |
Linnette Fontanez, RPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Carmelita Calle 15, #6, Vega Alta, PR 00692 Phone: 787-604-4248 Fax: 787-855-1565 |
Yadira Rodriguez Vargas Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Condominio Caribe Medical Plaza, Urb Santa Rita Parcelas J Bo Espinosa Suite M 101, Vega Alta, PR 00692 Phone: 787-638-5534 Fax: 787-915-5492 |
Antonia Santos-alicea, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 50 Calle Zafiro, Cond. Pisos De Santa Ana A-3, Vega Alta, PR 00692 Phone: 787-883-1100 Fax: 787-883-1100 |
News Archive
Two electronic medical record snafus in two weeks at a Midwestern hospital chain are raising questions about the safety of such health IT systems, The Huffington Post Investigative Fund reports.
For the millions of people who suffer from urinary tract infections each year and the doctors who treat them, a promising new biosensor technology has been developed that may replace antiquated testing methods and save precious health care dollars.
The debilitating pain and disability of migraine also attacks the emotional, social and financial fabric of a family, according to a new study conducted by researchers at Montefiore Headache Center, Albert Einstein College of Medicine, affiliated with the Uniformed Services University of the Health Sciences, Vedanta Research, the Mayo Clinic and Allergan plc. The findings were published today in Volume 91, Issue 5 of Mayo Clinic Proceedings.
Encouraging results from the T1DAL study (Targeting effector memory T cells with alefacept in new onset type 1 diabetes), led by Mark R. Rigby MD, PhD from Indiana University and Riley Hospital for Children in Indianapolis and sponsored by the Immune Tolerance Network (ITN) with additional support from JDRF, are published today in The Lancet Diabetes & Endocrinology.
› Verified 3 days ago